Among the few notable exceptions to the Dow’s generally down day on Monday was Foster City’s Gilead Sciences Inc., which climbed nearly 4 percent to close at $47.53. Could have something to do with the royalties they’re collecting on Tamiflu, the influenza drug the biotech company invented and sold to Swiss pharma Roche Holding AG in 1996. Prepare For The Swine Flu – See Ba...